Biogen (BIIB) PT Lowered to $343 at Wells Fargo
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $196.58 --0%
Rating Summary:
26 Buy, 17 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 7 | New: 21
Rating Summary:
26 Buy, 17 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 7 | New: 21
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal lowered the price target on Biogen (NASDAQ: BIIB) to $343.00 (from $350.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Biogen (BIIB) Reiterated at Overweight by Cantor Fitzgerald: Advancing with BIIB080
- MDA Space Ltd (MDA:CN) (MDA) PT Raised to Cdn$65 at Canaccord
- Scotiabank Resumes Parex Resources Inc. (PXT:CN) (PARXF) at Sector Perform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
